Home|Journals|Articles by Year|Audio Abstracts

Original Research

Evaluation of relationship between cytokine and chemokine levels measured by using multiplex laboratory method before and after treatment and clinical course and treatment response in rheumathoid arthritis patients receiving TNF-α blocker therapy

Atilla BULUR.

Cited by 1 Articles

Aim: The laboratory findings are non-specific in Rheumatoid arthritis (RA). We have based our study on this idea and chose cytokines and chemokine to evaluate ; we then tried to establish a relationship between the progress of the disease and the levels of these molecules before and 3-6 months after the TNF-α blocker treatment.
Material and Methods: A total of 34 RA patients (28 females, 6 males) who were diagnosed with RA and received TNF-α blocker therapy were included in the study.Blood samples were drawn from the patients before the TNF-α treatment began and then in the following 3rd and 6th months of the treatment.
Results: The mean age of the study group is 49.15±11.03. the mean disease period is 9.77±6.29 years and the mean treatment period is 6.88±4.33 years. 84.6% (n=22) of the study group is female and 15.4% (n=4) is male.Patients with good treatment response to TNF-α blocker treatment were younger than the patients with medium treatment response. The increase of mean hemoglobin (Hgb) levels between 0 and 6 months were statistically meaningful (both p

Key words: Rheumatoid Arthritis; TNF-α blocker treatment; cytokines; DAS28; disease activity.

Full-text options

Share this Article

Online Article Submission
• ejmanager.com

ejPort - eJManager.com
Refer & Earn
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.